Regarding the measurement of therapeutic adherence
<p>Adherence to chronic therapies among population living in developed countries has been estimated about 50% [1]. This is a matter of concern, since poor adherence is associated with suboptimal clinical outcomes, increased frequency of adverse effects and high healthcare expenses [2]. </p&...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications,
2020-04-17.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_ijpsdr_000026 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Sara Malo |e author |
| 245 | 0 | 0 | |a Regarding the measurement of therapeutic adherence |
| 260 | |b International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications, |c 2020-04-17. | ||
| 520 | |a <p>Adherence to chronic therapies among population living in developed countries has been estimated about 50% [1]. This is a matter of concern, since poor adherence is associated with suboptimal clinical outcomes, increased frequency of adverse effects and high healthcare expenses [2]. </p> | ||
| 540 | |a Copyright © Sara Malo et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Letter to Editor |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/ijpsdr.000026 |z Connect to this object online. |